X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2

Structure

Volumn 9, Issue 8, 2001, Pages 669-678

  Huang, D B ^a   Chen, Y Q ^a   Ruetsche, M ^a   Phelps, C B ^a   Ghosh, G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

c Rel; CD28RE; IL 2; Protein DNA complex; Proto oncogene; v Rel

Indexed keywords

AMINO ACID; CD28 ANTIGEN; DIMER; INTERLEUKIN 2; INTERLEUKIN 8; ISOPROTEIN; PROTEIN SUBUNIT; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR REL;

ARTICLE; BASE PAIRING; BINDING AFFINITY; CONFORMATION; CRYSTAL STRUCTURE; DIMERIZATION; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; DNA STRUCTURE; DRUG DNA BINDING; DRUG STRUCTURE; MOLECULAR RECOGNITION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANISOTROPY; ANTIGENS, CD28; BASE SEQUENCE; CHICKENS; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; INTERLEUKIN-2; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NF-KAPPA B; ONCOGENE PROTEINS V-REL; POINT MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-REL; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, FLUORESCENCE;

EID: 0034892132     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(01)00635-9     Document Type: Article

References (42)

1. NF-κ B: Ten years after
2. Function and activation of NF-kappa B in the immune system
3. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
4. Activators and target genes of Rel/NF-kappaB transcription factors
5. Regulation of DNA binding by Rel/NF-kappaB transcription factors: Structural views
6. The NF-kappa B and I kappa B proteins: New discoveries and insights
7. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells
8. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA
9. A novel DNA recognition mode by the NF-kappa B p65 homodimer
10. Structure of NF-kappa B p50 homodimer bound to a kappa B site
11. Structure of the NF-kappa B p50 homodimer bound to DNA
12. Structure of the human NF-kappaB p52 homodimer-DNA complex at 2.1 Å resolution
13. Structure of the specificity domain of the Dorsal homologue Gambif1 bound to DNA
14. Selection of optimal kappa B/Rel DNA-binding motifs: Interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation
15. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
16. Interleukin 2
17. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element
18. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28
19. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites
20. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2
21. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters
22. Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel
23. The v-Rel oncoprotein blocks apoptosis and proteolysis of I-kappa-B-alpha in transformed chicken spleen cells
24. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism
25. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300
26. The role of DNA in the mechanism of NF-κB dimer formation: Crystal structures of the dimerization domains of the p50 and p65 subunits
27. NF-κB p65 (RelA) homodimer uses distinct mechanisms to recognize DNA targets
28. Mechanism of kappa B DNA binding by Rel/NF-kappa B dimers
29. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers
30. Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein
31. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells
32. Selective activation of the proto-oncogene c-jun promoter by the transforming protein v-Rel
33. Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: Heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo
34. Solution structure of a non-palindromic 16 base-pair DNA related to the HIV-1 kappa B site: Evidence for BI-BII equilibrium inducing a global dynamic curvature of the duplex
35. How NF-kappaB can be attracted by its cognate DNA
36. NF-kappa B subunit-specific regulation of the interleukin-8 promoter
37. Activation of NF-kappa B in vivo is regulated by multiple phosphorylations
38. The CCP4 Suite: Programs for protein crystallography
39. AMoRe: An auomated package for molecular replacement
40. Crystallographic and NMR system: A new software system for macromolecular structure determination
41. Improved methods for binding protein models in electron density maps and the location of errors in these models
42. Tom: A Frodo subpackage for protein ligand fitting with interactive energy minimization